• Cellumed and ARTES Sign Development and License Agreement B3Cnewswire
    October 15, 2021
    Today, Cellumed Co. Ltd., listed stock market company and Germany based ARTES Biotechnology GmbH announce the execution of a Development and License Agreement aiming at the generation of microbial production cell lines...
PharmaSources Customer Service